The Energy Code

By Dr. Mike BelkowskiAlternative Health Health & Fitness

Favorites
50
Followers
Typical duration
55 min
per episode

Based on Podcast App listening data

The Energy Code episodes

June 02The “Missing Peptides” Behind AFib: Humanin + MOTS-c and the Fibrosis Switch
Atrial fibrillation is typically treated like an electrical glitch — rate control, rhythm control, anticoagulation. But this Deep Dive explores a newer frame: AFib may be driven by metabolic collapse and fibrotic remodeling rooted in mitochondrial dysfunction. Dr. Mike breaks down a May 5 Biomedicines paper titled “Humanin and MOTS-c attenuate atrial fibrillation by suppressing fibrosis and mitochondrial dysfunction,” highlighting why mitochondrial-derived peptides (MDPs) — Humanin and MOTS-c — may function as stress-responsive guardians that help preserve mitochondrial integrity, reduce oxidative stress, and blunt fibrosis. You’ll hear the key human tissue findings (both peptides downregulated in AFib atrial appendages), the biomarker signal (plasma MOTS-c inversely tracking NT-proBNP), the “Humanin paradox” (plasma up while atrial tissue down), and the mouse data showing peptide treatment reduced AFib inducibility and structural remodeling. The episode closes with a big question: if heart health is about fueling cellular engines, not just fixing wiring, how does that reshape aging medicine?
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction
-
Key Quotes From Dr. Mike:
“For decades, the medical establishment has approached AFib as an electrical failure…The true culprit may not be the wiring, but rather the power plants.”
“In patients with atrial fibrillation, these protective peptides essentially vanish... The more severe the peptide depletion, the more advanced the structural damage appeared to be.”
“Our study identifies down regulation of Humanin and MOTS-c as a novel feature of human afib that correlates with fibrosis... As Humanin and MOTS-c levels drop, collagen deposition and atrial fibrosis increase.”
“Humanin predominantly influences cell adhesion and immune response pathways, while mots C targets metabolic processes... They effectively attenuated structural remodeling and significantly reduced afib inducibility…”
“These micropeptides are born directly within the mitochondrial DNA... They are exercise sensitive myokines, meaning physical activity naturally stimulates their production.”
-
Key Points
The featured paper (May 5, Biomedicines): Humanin + MOTS-c attenuate AFib by suppressing fibrosis and mitochondrial dysfunction.
AFib is framed as a growing societal burden and a driver of stroke/heart failure; current therapies mainly manage the “wiring.”
Humanin + MOTS-c are mitochondrial-derived peptides encoded in mtDNA, acting as cytoprotective stress messengers.
AFib atrial tissue shows significant downregulation of both peptides (spatial transcriptomics + histology).
Severity link: more depletion → more structural damage/fibrosis.
Biomarker link: plasma MOTS-c is decreased and inversely correlates with NT-proBNP.
The “Humanin paradox”: Humanin depleted in atrial tissue but slightly elevated in plasma — blood levels can mislead.
In a mouse model, HNG (Humanin analog) + MOTS-c reduced AFib inducibility and structural remodeling.
Mechanistic themes: preserved mitochondrial ultrastructure, normalized fission dynamics, reduced hypertrophy, lowered IL-1β and IL-6.
Dual-pronged fibroblast control: Humanin influences adhesion/immune pathways, MOTS-c targets metabolic pathways.
-
Episode timeline
0:00–0:57 — Intro: peptide-focused season; “future of mitochondrial medicine”
0:57–2:32 — Paper setup + personal relevance; why AFib is a mitochondria-dense tissue problem
2:32–3:50 — Reframing AFib: from electrical “wiring” to mitochondrial “power plants” + micropharmacology
3:50–4:56 — Humanin + MOTS-c basics: mtDNA-encoded “guardians,” exercise-sensitive signaling
4:56–6:51 — Human atrial tissue findings: downregulation, severity correlation, MOTS-c vs NT-proBNP
6:51–7:56 — Fibrosis link + RAAS context; peptides as complementary anti-scarring pathway
7:56–9:47 — Mouse model: HNG + MOTS-c outcomes (ultrastructure, fission, hypertrophy, cytokines)
9:47–11:15 — The Humanin paradox: plasma vs tissue concentration; biomarker caution
11:15–12:20 — Fibroblast behavior + RNA-seq: Humanin vs MOTS-c “two angles”
12:20–13:26 — Synthesis + limitations + closing question (“fueling the cell” paradigm)
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight Labs:
Website
Instagram

BioLight:
Website
Instagram
YouTube
Facebook
15 min
May 28MitoQ, SS-31, Mitophagy, and Mito-Transplants: The Future of SCI Repair
Spinal cord injury is usually framed as a permanent structural problem — axons torn, connections lost, paralysis inevitable. This Deep Dive flips that assumption: the real long-term roadblock may be a secondary mitochondrial energy crisis that turns a helpful early scar into a toxic, permanent barrier. Using a 2026 Frontiers in Neurology review, Dr. Mike and Don unpack how ATP collapse, ROS signaling, failed mitophagy, and mtDNA “false infection” alarmsdrive chronic sterile inflammation, fibrotic hardening, and growth cone collapse. Then they explore the new therapeutic frontier: mitochondria-targeted antioxidants (MitoQ), membrane stabilizers (SS-31), NAD+/AMPK reprogramming, fission/fusion tuning (DRP1/MFN2), mitophagy restoration (PINK1/Parkin, BNIP3/NIX), and even mitochondrial delivery + mtDNA base editing — with the critical caveat: timing matters, because the early scar is initially protective.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
Effect of mitochondrial dysfunction on scar formation after spinal cord injury
-
Key Quotes From Dr. Mike:
“What if the real reason the nerves can’t heal is actually a microscopic energy crisis?”
“This entire battle is governed by the powerhouses of our cells, the mitochondria.”
“In a severe spinal cord injury, that recycling process… mitophagy… completely fails.”
“SS-31… physically binds and stabilizes the cardiolipin… preventing cytochrome C release... It acts like an emergency fuel drop.”
“The answer lies in sustained mitochondrial failure.”
-
Key Points
SCI disability isn’t only the “cut” — it’s the secondary metabolic battle that follows.
Early glial scar formation is protective: it walls off necrotic tissue and contains inflammation.
Acute mitochondrial rupture causes ATP drop + moderate ROS burst that acts as an alarm:
ROS → STAT3 activation in astrocytes (glial boundary)
ROS → TGF-β1 activation in fibroblasts (ECM deposition)
Chronic problem: mitophagy failure leaves fragmented mitochondria leaking mtDNA + excess ROS.
Leaked mtDNA looks “bacterial,” driving sterile inflammation via NLRP3 and sustained microglial activation.
Chronic inflammatory signaling stabilizes HIF-1α → fibrosis hardens; astrocytes secrete CSPGs that repel axon regrowth.
Regenerating axons fail via growth cone collapse from local ATP scarcity + toxic environment.
Interventions target the power grid, not just the scar:
MitoQ (TPP “VIP pass” into mitochondria) scavenges ROS at the source.
SS-31 stabilizes cardiolipin → prevents cytochrome-c leak/apoptosis.
AMPK agonists + NAD+ precursors (NMN/NR) boost energy + suppress NF-κB inflammation.
DRP1 inhibitors / MFN2 agonists restore fission–fusion balance.
PINK1/Parkin + BNIP3/NIX reboot mitophagy and clear damaged mitochondria.
“Sci-fi tier”: mitochondrial delivery (nanocarriers, MSC exosomes, iPSCs) + mtDNA base editing (DDCBE via AAV).
Translational bottleneck: spatiotemporal timing — block scarring too early and you remove the protective “sandbag wall.”
-
Episode timeline
0:19–1:30 — Premise: paralysis as a secondary energy crisis; 2026 Frontiers in Neurology review introduced
1:30–2:31 — Shift from structural damage to metabolic pathology
2:31–5:20 — Acute phase: mitochondrial rupture → ATP drop + ROS alarm → STAT3 astrocytes + TGF-β1 fibroblasts → protective boundary
5:20–6:49 — Why the protective wall becomes a permanent roadblock: sustained mitochondrial failure
6:49–9:47 — Mitophagy failure → mtDNA/ROS leak → “false infection” → NLRP3, HIF-1α fibrosis, CSPGs, growth cone collapse (ATP starvation)
9:47–12:54 — Targeted mitochondrial pharmacology: MitoQ delivery logic; SS-31 cardiolipin stabilization
12:54–13:55 — Metabolic reprogramming: AMPK agonists + NAD+ precursors → energy support + NF-κB suppression
13:55–16:45 — Dynamics + cleanup: DRP1/MFN2 tuning; PINK1/Parkin, BNIP3/NIX mitophagy + ubiquitin “barcode” clearance
16:45–19:55 — “New hardware” strategies: mito-nanocarriers, MSC exosomes, iPSCs; mtDNA editing (DDCBE/AAV), HDAC inhibitors, ncRNAs
19:55–20:53 — The timing problem: preserve early protective scar, prevent later inhibitory scar
20:53–22:23 — Final synthesis + fibrosis crossover question; close
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
23 min
May 22Nature’s Mitochondrial Assassins: The Ocean-to-Garden Blueprint for Killing Cancer
What if the next leap in cancer therapy doesn’t come from a billion-dollar lab — but from sea sponges, brown seaweed, fungi, and everyday plants? In this Deep Dive, Dr. Mike and Don unpack a 2025 review on natural compounds that target cancer by attacking mitochondrial metabolism — the tumor’s true center of gravity. You’ll learn how cancer “hotwires” its mitochondria for growth, blocks apoptosis with BCL-2 “bouncers,” and even hijacks mitophagy to survive starvation. Then we break down how compounds like CBD, curcumin, resveratrol, EGCG, fucoidan, and marine/fungal molecules can drain mitochondrial voltage, overload oxidative stress, trigger lethal mitophagy, or cut glutamine supply lines. Finally, we tackle the real bottleneck — delivery — and why conjugates, gold nanoparticles, nanoencapsulation, and synthetic biology may be the bridge from petri-dish magic to real-world oncology.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
Natural compounds targeting mitochondrial metabolism in cancer therapy: a literature review
-
Key Quotes From Dr. Mike:
“Natural compounds… can actually be weaponized against the very unique way a cancer cell feeds itself.”
“The tumor massively overproduces those BCL2 bouncers... CBD aggressively drains that battery… the BCL2 bouncers literally lose their grip.”
“Curcumin… clogs the exhaust pipes until the factory suffocates on its own fumes.”
“Resveratrol… triggers what we call lethal mitophagy.”
“EGCG doesn’t just attack the power plant, it cuts off the supply lines entirely.”
“Gold nanoparticles are… microscopic armored vehicles... It’s basically a Trojan horse made of gold.”
-
Key Points
Cancer mitochondria aren’t “broken” (Warburg was incomplete) — tumors reprogram mitochondria into biosynthetic superfactories.
Tumors rely on fatty acid oxidation and often become glutamine-addicted to feed the TCA “manufacturing hub.”
Mitochondria also control apoptosis; cancer survives by overexpressing BCL-2 to block BAX/BAK pore formation and cytochrome c release.
Mitophagy is a paradox: early tumor suppression vs. later survival cannibalism under hypoxia/starvation.
Natural compounds target key failure points:
CBD: drops mitochondrial membrane potential → releases apoptotic blockade.
Curcumin: amplifies ROS + mtDNA damage → mitochondrial rupture/apoptosis.
Resveratrol: pushes mitophagy into lethal overdrive.
EGCG: blocks glutamine utilization (cuts supply lines).
Fucoidan: reduces anti-apoptotic defenses across multiple proteins.
Marine/fungal agents: uncoupling, ETC complex blockade, ER stress cascades.
Biggest barrier: bioavailability + rapid metabolism (“forgot the zip code”).
Solutions: drug hybrids/conjugates, gold nanoparticles, nanocarriers, and synthetic biology fermentation for scalable supply.
Final provocative arc: if we can deliver payloads to kill tumor mitochondria, can we use the same delivery logic to repair mitochondria in aging?
-
Episode timeline
0:19–1:18 — Hook + episode premise: nature as an anti-cancer weapons lab; source paper introduced
1:18–2:25 — Why this matters: cancer scale + limits of “blunt instrument” therapies
2:25–4:24 — Warburg effect explained (glycolysis “backup generators”) and why the old assumption misled the field
4:24–6:31 — Metabolic reprogramming: mitochondria as tumor superfactories; fatty acid oxidation + glutamine dependence
6:31–9:15 — Apoptosis control: BCL-2 “bouncers,” BAX/BAK “cops,” cytochrome c “fire alarm”
9:15–10:59 — Mitophagy paradox: tumor suppression → survival cannibalism in hypoxic/starved tumor cores
10:59–15:18 — Plant compounds mechanics: CBD (voltage), curcumin (ROS), resveratrol (lethal mitophagy), EGCG (glutamine blockade)
15:18–19:07 — Marine + fungal compounds: fucoidan; sponge uncouplers; ER-stress triggers; ETC complex blockers
19:07–20:48 — The “zip code” problem: bioavailability, metabolism, delivery failure in humans
20:48–23:19 — Delivery solutions: conjugates/hybrids, gold nanoparticles, nanoencapsulation
23:19–24:30 — Scaling without ecosystem damage: synthetic biology “brew the medicine”
24:30–26:21 — Final synthesis + aging crossover question (deliver killers vs. deliver repair)
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
27 min
May 21Mitophagy: The Cellular Cleanup System That Decides Aging, Heart Disease, and Vision Loss
Mitophagy sounds technical — until you realize it may be one of the most important biological processes behind aging, cardiovascular disease, eye degeneration, inflammation, and cellular energy. In this episode, Dr. Mike and Don break down three recent scientific reviews that converge on one central message: when mitochondrial cleanup fails, tissues don’t just lose ATP — they become inflamed, oxidatively stressed, and vulnerable to disease. You’ll learn the difference between autophagy and mitophagy, why damaged mitochondria act like inflammatory “danger beacons,” what this looks like in Fabry disease cardiomyopathy, inflammatory cardiovascular disease, and ophthalmic diseases like glaucoma/AMD/diabetic retinopathy — and why the future of mitochondrial medicine is about restoring the rhythm of removal + renewal.
(Educational content only, not medical advice.)
-
Articles Referenced in Episode:

Mitophagy in ophthalmic pathologies: Molecular mechanisms and therapeutic implications

Understanding Dysfunctional Autophagy and Mitophagy in Inflammatory Cardiovascular Disease

Early mitophagy defects and impaired mitochondrial energy metabolism drive target organ damage progression: lessons from the Fabry heart
-
Key Quotes From Episode:
“Mitophagy… means the body’s process for identifying damaged mitochondria, removing them, and making room for healthier mitochondria to take their place.”
“When mitochondrial cleanup fails, the cell doesn’t just lose energy — it becomes inflamed, stressed, and vulnerable to disease.”
"Mitochondrial quality control is not a side issue. It may be one of the central mechanisms that determines whether high-demand tissues stay resilient or begin to fail.”
“A healthy cell is always asking: which mitochondria are still efficient, and which ones are leaking too much oxidative stress?”
“Mitophagy is the process that removes the liabilities.”
“Damaged mitochondria are not just weak energy producers. They can actually become inflammatory.”
-
Key Points
Autophagy = general cellular recycling; mitophagy = targeted recycling of damaged mitochondria.
Mitochondria are dynamic networks, not static “batteries” — they’re constantly tested, repaired, fused/fissioned, and removed.
Damaged mitochondria don’t just make less ATP—they can trigger sterile inflammation by leaking ROS, mtDNA, cardiolipin, etc.
Fabry disease heart model: lysosomal dysfunction → impaired mitophagy → damaged mitochondria → less ATP + more ROS → worse lysosome function (a mito–lysosomal vicious cycle).
Inflammatory cardiovascular disease: damaged mitochondria activate inflammatory pathways (e.g., NLRP3) and worsen vascular/heart pathology.
Ophthalmology: retina is extremely energy-hungry; mitophagy failure contributes to glaucoma/AMD/diabetic retinopathy vulnerability.
Shared “cast” across tissues: PINK1/Parkin, BNIP3/NIX/FUNDC1, AMPK–mTOR, sirtuins, FOXO3, PGC-1α(cleanup + rebuilding).
The winning strategy isn’t “maximize mitophagy” — it’s balanced flux: remove damaged mitochondria and replace them via biogenesis.
-
Episode timeline
00:00–03:30 — Cold open: why mitophagy changes how you think about aging, heart health, eye health, inflammation, energy
03:30–09:00 — Definitions: autophagy vs mitophagy + “city waste management” analogy
09:00–14:30 — Core principle: damaged mitochondria as inflammatory triggers (sterile inflammation)
14:30–27:30 — Paper 1 (Fabry + heart): lysosome impairment → impaired mitophagy → early mitochondrial dysfunction → vicious cycle; early-before-symptoms concept
27:30–39:30 — Paper 2 (inflammatory cardiovascular disease): mtDNA/ROS danger signals → NLRP3 + immune activation; mitophagy as anti-inflammatory defense
39:30–49:00 — Paper 3 (eye disease): retina energy demand; mitophagy failure in glaucoma/AMD/diabetic retinopathy; why visual tissues are vulnerable
49:00–54:30 — Unified model: “high-demand tissues + failed cleanup = energy loss + chronic inflammation + degeneration”
54:30–56:12 — Final synthesis: mitophagy = energy defense + immune regulation; “removal + renewal” rhythm
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
Facebook
57 min
May 20Photobiomodulation vs. Fracture Pain: The Meta-Analysis That Changes Trauma Care
What if a fractured wrist didn’t automatically mean weeks of brutal pain — and a medicine cabinet full of NSAIDs or opioids? In this Deep Dive, Dr. Mike and Don break down a 2026 systematic review and meta-analysis (12 randomized controlled trials across 5 countries, ~500 patients) showing that photobiomodulation (red/near-infrared light) can significantly reduce acute fracture pain, improve early upper-limb grip strength, and dramatically reduce sleep-wrecking nocturnal pain — all without reported side effects. You’ll learn why this isn’t “heat therapy,” how mitochondria and cytochrome c oxidase translate photons into biochemical calm, why results are strongest early (and fade later), and what the evidence does not yet prove about speeding true bone knitting on X-ray.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
Effect of photobiomodulation on pain relief and functional improvement in fractures: a systematic review and meta-analysis
-
Key Quotes From Dr. Mike:
“At the 1-week mark… pain scores were significantly lower in the group receiving photobiomodulation.”
“At 4 weeks out… grip strength was significantly greater in the light therapy group.”
“The risk of experiencing severe sleep-disrupting nocturnal pain was cut exactly in half.”
“Photobiomodulation primarily targets the acute inflammatory phase.”
“When you irradiate the fracture site directly… you’re acting locally… But laser acupuncture acts systemically.”
-
Key Points
PBM is photochemical, not photothermal — it’s not a heating pad.
Mechanism centers on cytochrome c oxidase (mitochondria) → ↑ATP + signaling (NO, Ca²⁺, low “healthy” ROS).
Acute pain reduction is strongest at ~1 week vs. sham treatment (VAS/NRS).
Nocturnal pain risk cut ~in half (reported risk ratio ~0.49) → major quality-of-life and recovery leverage.
Upper-limb fractures: ~+5 kg grip strength improvement around week 4 vs placebo.
PBM can work locally (fracture site) and systemically (laser acupuncture points) via neurochemical pain pathways (endorphins, serotonin/norepinephrine, spinal gating/DNIC).
Long-term (4–26 weeks): differences in pain/function often wash out as recovery enters remodeling phase.
Evidence for faster radiographic bone healing is inconsistent across trials.
Energy density window for analgesia looks broad; wavelength matters more (NIR penetrates deeper than red).
Big gap: trials largely didn’t measure angiogenesis endpoints, which may matter for longer-term remodeling.
-
Episode timeline
0:19–1:26 — Fracture scenario + why alternatives to NSAIDs/opioids matter
1:26–2:51 — Source setup: 2026 systematic review/meta-analysis (12 RCTs; 5 countries; ~500 patients)
2:51–4:16 — “Not a heating pad”: photochemical vs photothermal PBM
4:16–6:12 — Mechanism: mitochondria → cytochrome c oxidase → ATP + NO/Ca²⁺/low ROS signaling
6:12–7:55 — Why fractures hurt: periosteum + inflammation + swelling + spasm; NO → microcirculation + waste clearance
8:19–9:18 — Main early outcome: lower pain at 1 week (VAS/NRS; sham-controlled)
9:21–10:30 — Function: grip strength improved at 4 weeks (+5 kg) in upper-limb fractures
10:41–13:56 — Local PBM vs laser acupuncture: endorphins + neurotransmitters + spinal “circuit breaker” (DNIC)
14:20–16:23 — Why effects fade later: PBM targets acute inflammatory phase more than long remodeling
16:53–17:38 — Radiographic healing: inconsistent evidence for faster cortical bridging/BMD
18:43–21:05 — Parameters: broad effective energy-density range for analgesia; NIR penetrates deeper than red
21:12–22:24 — Missing metrics: angiogenesis not evaluated in included trials
22:36–23:09 — Long-term tracking tools (e.g., PRWE) vs simple pain scales
23:14–24:18 — Nocturnal pain finding: risk ratio ~0.49 (sleep-disrupting pain roughly halved)
24:41–26:15 — Synthesis: best-supported benefits + what PBM isn’t (not proven to speed full bone knitting)
26:33–27:36 — Closing question: why isn’t this standard in trauma care yet?
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
28 min
May 15GLP-1 Drugs Don’t Just Kill Appetite — They Rebuild a 20-Nanometer ‘Power Cable’ Inside Your Cells
Most people think “metabolic treatment” means fewer cravings and a changing number on the scale. This Deep Dive goes microscopic — into the ER–mitochondria contact sites (mito-ERCS) where metabolic dysfunction may begin as a structural failure, not just a hormone problem.
Using the paper “GLP-1 receptor and mitochondria contact sites: an emerging mechanism of metabolic regulation,” Dr. Mike and Don explain how chronic metabolic stress can sever a ~20-nanometer communication bridge between the endoplasmic reticulum (cellular “factory”) and mitochondria (cellular “power plant”). Then they explore a provocative idea: GLP-1 receptor agonists may work partly by forming localized “signalosome” hubs at these contact sites — boosting cAMP right where it’s needed — to upregulate MFN2, a tethering “winch” that helps pull fragmented mitochondria back into proper contact and restore calcium/lipid exchange and metabolic flexibility.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
GLP-1 receptor and Mitochondria-ER Contact Sites: an emerging mechanism of metabolic regulation
-
Key Quotes From Dr. Mike:
“The paper introduces a breakthrough concept here called signalosomes.”
“GLP-1 receptors physically organize into specialized, highly concentrated hubs… directly at the site of the severed connection.”
“Could targeting these microscopic contact sites hold the key to reversing the cellular decay of aging itself?”
“When your body enters a state of chronic metabolic dysfunction, the stress acts like a biochemical wrecking ball inside that factory.”
“These GLP-1 therapies are far more than just systemic appetite suppressants… They are literal microscopic architects.”
-
Key Points
Metabolic disease may involve physical disruption of ER–mitochondria contact sites (mito-ERCS), not only “slow metabolism” in a vague sense.
The paper frames mito-ERCS as a ~20 nm bridge enabling critical ER↔mitochondria communication.
Chronic stress is described as triggering an ATF4 → PDE4D → cAMP degradation cascade, contributing to bridge failure.
When contact sites fail, mitochondria can fragment, contributing to an “energy crash” phenotype.
GLP-1 receptors may assemble into localized signalosomes at mito-ERCS — targeting repair rather than broadcasting diffuse signaling.
Local cAMP signaling can promote MFN2 upregulation, helping re-tether mitochondria back to ER at the correct distance.
Restored contact sites may normalize calcium and lipid transfer, supporting metabolic flexibility.
Big takeaway: GLP-1s may be cellular architects, not just appetite suppressants — raising the question of whether “contactomics” could extend into aging biology.
-
Episode timeline
0:19–0:41 — Intro: metabolic treatment isn’t just “scale changes”; we’re going microscopic
1:00–1:18 — Grounding paper: GLP-1 receptor + mitochondria contact sites as metabolic regulation
1:34–2:11 — Core architecture: ER as “factory,” mitochondria as “power plant,” bridged by ~20 nm contact sites
2:11–3:18 — Metabolic collapse model: chronic stress → ATF4 → PDE4D → cAMP loss → contact sites sever + mitochondrial fragmentation
3:27–4:20 — Main question: how do GLP-1 therapies fix a precise structural failure without chaotic signaling?
4:09–4:56 — “Signalosomes”: GLP-1 receptors form concentrated hubs at mito-ERCS (targeted repair zone)
4:56–5:36 — Local cAMP boost → MFN2 upregulation: the “winch” that re-tethers and rebuilds the bridge
5:36–6:25 — Function restored: calcium/lipid exchange resumes; factory + power plant back online
6:25–7:13 — Bigger implication: GLP-1s as “microscopic architects”; does contactomics extend to aging?
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
8 min
May 14Mitohormesis & The Goldilocks Zone of Longevity
This episode of The Energy Code reframes mitochondria from “powerhouses” into master environmental sensors — and explains why mild cellular stress can be the very signal that upgrades your biology. Dr. Mike and Don unpack mitohormesis: the bell-curve logic where too much stress destroys cells, too little causes stagnation, and the “just right” dose triggers repair, resilience, and longer healthspan. You’ll learn how mitochondria “shout” to the nucleus through stress pathways like UPRmt and the Integrated Stress Response (ISR) — including an elegant “fire alarm” cascade (OMA1 → DLE1 cleavage → HRI → eIF2α → ATF4). Then the lens widens from single-cell survival to whole-body adaptation via mitokines like FGF21 and GDF15 (appetite suppression, energy expenditure), plus mitochondrial peptides like MOTS-c. The episode connects this to exercise, fat “browning,” stem-cell hypoxic “seed vaults,” and the darker edge: how cancer hijacks the same survival program to create therapeutic resistance. Finally, it hits the headline takeaway: the future isn’t “eliminate all stress with antioxidants” — it’s precision control of the Goldilocks zone.
(Educational content only, not medical advice.)
-
Articles Referenced in Episode:
Mitohormesis

Mammalian mitohormesis: from mitochondrial stressors to organismal benefits

Mitohormesis; Potential implications in neurodegenerative diseases

Mitohormesis and mitochondrial dynamics in the regulation of stem cell fate

MITOHORMESIS: THE CORNERSTONE OF THERAPEUTIC RESISTANCE IN CANCER CELLS
-
Key Quotes From Episode:
“Mitohormesis is essentially weightlifting for your cellular engines.”
“The very thing causing the damage… is the required key to turn on the system that builds the fire extinguishers.”
“Regular physical exercise is, at its core, a mitohormetic stressor.”
“If you hit an optimal threshold of mild to moderate mitochondrial stress… it triggers a beneficial, highly active adaptive response.”
“We need to start looking at [mitochondria] as the master environmental sensors of the entire human body.”
-
Key Points
Mitohormesis = a nonlinear (bell-curve) response:
too much stress → mitochondrial rupture → inflammation → apoptosis
too little stress → no upgrades (stagnation)
“just right” stress → adaptive reprogramming → resilience + longevity
Mitochondria are framed as environmental sensors, not just ATP factories.
Key triggers: ROS, misfolded proteins, hypoxia, fasting/substrate deficiency, mtDNA mutations.
Core “fire alarm” signaling described: OMA1 cleaves DLE1 → DLE1S activates HRI → eIF2α → ATF4 → DNA-level survival reprogramming.
ATF4 shifts metabolism, boosts amino acid import, supports DNA repair via one-carbon metabolism, restores redox balance via endogenous antioxidants (e.g., glutathione).
Built-in redundancy: “import arrest” still triggers ISR when DLE1 accumulates outside the mitochondria.
Systemic mitohormesis: stressed tissues secrete mitokines that upgrade distant organs.
Examples:
FGF21 → higher energy expenditure + fat metabolism signaling
GDF15 crosses BBB → appetite/taste aversion (energy conservation + toxin avoidance)
MOTS-c → improves metabolic homeostasis + exercise capacity
NAT (N-acetyl-L-tyrosine) → induces tiny ROS burst → activates FOXO/KEAP1/Nrf2 defense axis
Exercise is framed as the most reliable, natural Goldilocks stressor: ROS + low ATP + hypoxia → ISR/mitokines → whole-body resilience.
Stem cells live in hypoxic “seed vault” niches to preserve stemness and avoid ROS damage; differentiation requires fusion → OXPHOS surge → ROS signal.
Dark side: cancer can hijack mitohormesis → therapeutic resistance; precision medicine must both trigger and block these pathways contextually.
-
Episode timeline
00:00:37–00:02:25 — The paradox: stress/toxins/starvation can upgrade cells → mitohormesis defined
00:02:25–00:04:34 — Research stack overview (Gunawan 2025; Barzegari 2022; Cheng/Liu/Finkel 2024; Gohil/Singh 2021; Boet 2024) + thesis: mitochondria as sensors
00:04:46–00:06:40 — Hormesis history + “dose makes the poison” → bell curve explained
00:06:40–00:10:23 — Three zones: catastrophic failure vs stagnation vs Goldilocks adaptation; strength-training analogy
00:10:23–00:13:32 — “Cellular dumbbells”: ROS, misfolded proteins, hypoxia, fasting, mtDNA mutations
00:13:32–00:24:28 — How mitochondria signal the nucleus: UPRmt + ISR; deep dive into OMA1 → DLE1 → HRI → eIF2α → ATF4 + redundancy via import arrest
00:24:28–00:29:31 — From one cell to the whole organism: systemic mitohormesis + mitokines
00:29:31–00:33:10 — NAT discovery (army worm → humans): controlled ROS “match” → KEAP1/Nrf2 defense amplification
00:33:10–00:37:28 — Exercise redefined: mitohormetic stressor → mitokines → whole-body upgrades + white fat browning
00:37:28–00:47:44 — Stem cell fate (Barzegari 2022): hypoxic niches, HIF1α, glycolysis, “seed vault” model; fusion/fission dictates stemness vs differentiation
00:47:44–00:49:55 — Dark pivot: cancer hijacks mitohormesis → therapeutic resistance; Warburg framing introduced
00:49:56–00:58:34 — Aging/Alzheimer’s + interventions: “ring the alarm”; urolithin A (postbiotic → mitophagy); antioxidant paradox setup + Ristow 2009 (C+E blunting exercise adaptation)
00:58:34–01:02:17 — Synthesis: mitochondria as sentries; precision medicine = manage Goldilocks zone; modern comfort “signal deprivation” question
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
Facebook
1 hr 3 min
May 13C60 vs. Sepsis: The Nanomaterial That Shielded Liver, Heart, and Brain
Sepsis is deadly on its own — but in diabetes, the baseline oxidative stress turns it into a full-blown organ-killing fire. In this Deep Dive, Dr. Mike and Don unpack a new study where water-soluble, hydroxylated fullerene C60 acts like a nanoscale “electron sink,” neutralizing free radicals the way depleted antioxidant enzymes can’t. In a diabetic sepsis model (CLP), C60 sharply reduced lipid peroxidation and protected multiple organ systems — liver, heart, and brain — while also boosting native antioxidant capacity (catalase). The big question: is this just an acute rescue tool… or a future prophylactic “organ armor” strategy?
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
Effects of fullerenol C60 on the liver, heart and brain tissues of streptozotocin‑induced diabetic rats with sepsis
-
Key Quotes From Dr. Mike:
"Think of sepsis as a massive fire breaking out in a house… and diabetes like having gasoline already spilled all over the floor."
Regarding C60: “It has this amazing capacity to attract and neutralize rogue, unbalanced electrons from free radicals.”
“In the liver, there was vastly reduced hepatocyte necrosis.”
“In the heart, they saw reduced interstitial fibrosis and way less myocardial disorganization.”
“They noted a major decrease in inflammatory cellularity in the brain.”
“It’s (C60) not just blocking the fire—it’s like upgrading the body’s sprinkler system.”
-
Key Points
Diabetes pre-loads the system with oxidative stress, making sepsis dramatically more damaging.
The model: polymicrobial sepsis via CLP in diabetic rats.
“Regular” C60 is insoluble/toxic in biology, but hydroxylated C60 becomes water-soluble and biologically usable.
Mechanism frame: C60 as an “aggressive electron sink” that neutralizes free radicals and mimics SOD-like activity.
Marker shift: TBARS ↓ (less lipid peroxidation / less membrane damage).
Organ protection signals:
Liver: necrosis ↓; AST/ALT/GGT/bilirubin ↓
Heart: fibrosis ↓; myocardial disorganization ↓
Brain: inflammatory cellularity ↓ (macrophages, astrocytes)
Not just a shield: catalase activity ↑, suggesting support of native defenses.
Closing provocation: could daily use in vulnerable populations precondition organs against oxidative storms?
-
Episode timeline
00:00:19–00:00:52 — Show intro + mission: C60 study + sepsis organ failure in diabetics
00:00:52–00:01:42 — Model setup: diabetic rats + polymicrobial sepsis via CLP
00:01:42–00:02:26 — Why diabetes worsens sepsis: chronic hyperglycemia → higher ROS baseline (“gasoline on the floor”)
00:02:26–00:03:28 — Key chemistry: insoluble/toxic C60 vs hydroxylated, water-soluble C60
00:03:28–00:04:28 — Mechanism: nanoscale “soccer ball” + alternating bonds → electron sink / SOD-mimic framing
00:04:28–00:04:59 — Oxidative damage readout: TBARS ↓ → lipid peroxidation reduced
00:04:59–00:05:37 — Liver protection: necrosis ↓; enzymes (AST/ALT/GGT/bilirubin) ↓
00:05:37–00:05:58 — Heart protection: fibrosis ↓; myocardial disorganization ↓
00:05:58–00:06:05 — Brain protection: inflammatory cellularity ↓ (macrophages/astrocytes)
00:06:05–00:06:29 — Endogenous defenses: catalase activity ↑ (“upgrading the sprinkler system”)
00:06:29–00:07:25 — Takeaway + global sepsis scale + provocative prevention question (daily prophylaxis?)
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
8 min
May 12Your Mitochondria Have a Self-Destruct Button (Here’s the “Death Finger” That Pulls It)
Mitochondria aren’t just your cell’s power plants — they may also contain a built-in kill switch. In this Deep Dive, Dr. Mike unpacks a 2026 Annual Review of Biophysics paper arguing that ATP synthase (the same machine that makes your ATP) can morph into the mitochondrial permeability transition pore (PT pore) under severe stress — especially calcium overload. You’ll learn the “death finger” model (subunit-e pulling a lipid plug), why cyclophilin D and inorganic phosphate help trigger the switch, and why this matters for real-world tissue injury like stroke and heart attack reperfusion damage. Then comes the twist: brine shrimp (sea monkeys) appear to lack this lethal pore — thanks to a tiny structural tweak that may hint at future strategies to “relax the tension” and keep our cellular dams from blowing.
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
The Mitochondrial Permeability Transition Pore: Past, Present, and Future
-
Key Quotes From Dr. Mike:
“For decades, the exact molecular identity of the self-destruct mechanism was a huge mystery in biophysics.”
“Your mitochondria actually have exactly that — a built-in kill switch.”
“When your mitochondria get overwhelmed by too much calcium, they can open up the permeability transition pore.”
“You can picture it as a literal finger hooking into a fatty lipid plug... When there’s a massive overload of calcium, that structural finger just pulls the plug.”
“We are basically carrying around a vital energy machine that moonlights as an executioner.”
-
Key Points
The PT pore is framed as a mitochondrial kill switch that opens under extreme stress (notably calcium overload).
Modern consensus points toward ATP synthase as the structural basis of the PT pore.
“Death finger” model: ATP synthase subunit-e acts like a finger pulling a lipid plug — turning an energy machine into a destructive leak.
Cyclophilin D (CypD) behaves like a foreman, helping order the pore to open.
Inorganic phosphate is the paradoxical accelerator: despite binding calcium, it changes CypD’s binding behavior, promoting pore opening.
Some species (e.g., Artemia franciscana / brine shrimp) appear to lack functional PT pore, tolerating huge calcium loads and hypoxia.
Brine shrimp subunit-e has ~15 extra amino acids, creating “slack” that prevents the plug from being pulled.
If we can mimic that “relaxed tension,” we may reduce reperfusion injury after stroke/heart attack.
-
Episode timeline
00:00:19–00:00:59 — Setup: mitochondria as power plants… with a surprise self-destruct button
00:01:00–00:01:34 — PT pore basics: calcium overload → swelling, energy collapse, death signaling
00:01:35–00:02:31 — ATP synthase as the likely pore-former: “hydroelectric dam” turning into a floodgate
00:02:32–00:03:20 — “Death finger” model: subunit-e + lipid plug → drain pulled open
00:03:21–00:04:46 — CypD + inorganic phosphate paradox: the “calming” molecule that helps open the gate
00:04:47–00:05:27 — Evolution question: if this kills cells, why wasn’t it removed?
00:05:28–00:05:57 — Brine shrimp (sea monkeys): mitochondria tolerate calcium/hypoxia without PT pore activation
00:05:58–00:06:32 — The structural hack: +15 amino acids on subunit-e = slack that prevents unplugging
00:06:33–00:07:22 — Clinical relevance: reperfusion injury + the hope of mimicking “relaxed tension” in humans
00:07:23–00:07:37 — Wrap + closing thought: maybe the kill switch has a purpose we don’t fully understand (yet)
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
8 min
May 11Razor-Thin Medicine: When Methylene Blue Rescues Mitochondria… and When It Becomes Poison
Emergency medicine is built on brute force — shock the heart, slam vasopressors, crank the numbers. But septic shock exposes the flaw in that instinct: the harder you squeeze vessels from the outside, the more you can starve the microcirculation that actually feeds the kidneys, liver, and lungs. In this Deep Dive, we unpack a 2026 Biomedicine & Pharmacotherapy study testing methylene blue as a precision countermeasure for vasoplegic septic shock. The core mechanism: cytokine-driven iNOS overexpression floods nitric oxide, overactivating the NO → sGC → cGMPrelaxation cascade and collapsing vascular tone. Instead of “chemical duct tape” (high-dose catecholamines), methylene blue blocks the pathway at the source—oxidizing sGC’s heme iron to prevent NO binding and inhibiting further NO production—while also acting as a redox-active electron carrier under oxidative stress. In a CLP sepsis model, 10 mg/kg produced the “Goldilocks” effect: improved MAP, protected lungs and kidneys, reduced IL-1β, boosted antioxidant defenses (SOD, GSH), and lowered lipid peroxidation (MDA). But at 100 mg/kg, the pharmacology flipped—pro-oxidant stress, catastrophic liver injury, and early death. The episode closes with the translational bridge: rat-to-human scaling places the effective dose around ~1.6 mg/kg, aligning with real ICU protocols, while highlighting key limitations (12-hour window, lactate lag, female-only cohort and estrogen effects).
(Educational content only, not medical advice.)
-
Article Discussed in Episode:
Dose-dependent effects of methylene blue on hemodynamics, cytokines, oxidative stress, and organ dysfunction in a rat model of CLP-induced sepsis: An experimental study
-
Key Quotes From Dr. Mike:
“In emergency medicine, the instinct is always to overpower the crisis with brute force.”
Regarding vasoplegia: "The engine driving it is an overproduction of nitric oxide.”
“Methylene blue… oxidizes the heme iron… preventing nitric oxide from binding to sGC.”
“It (methylene blue) restores normal vascular tone without aggressively squeezing the vessel from the outside.”
“At super-therapeutic concentrations, methylene blue stops acting as an efficient electron carrier... Instead of smoothly passing electrons… it begins indiscriminately stealing electrons and auto-oxidizing.”
“That is the inherent danger of redox-active compounds.”
-
Key Points
Septic shock punishes “brute force” care: raising MAP can collapse microvascular perfusion and accelerate organ failure.
Core driver of vasoplegia: iNOS → excess NO → sGC activation → cGMP surge → vascular smooth muscle relaxation.
Standard vasopressors “fight from the outside,” risking regional hypoperfusion, ischemia, and organ injury.
Methylene blue “fixes from the inside”: prevents NO binding to sGC (heme oxidation) and reduces NO production.
In CLP sepsis (dynamic polymicrobial model), 10 mg/kg improved MAP and organ protection without high-dose pressors.
Cellular redox rescue: ↑ SOD/GSH, ↓ MDA (lipid peroxidation), ↓ IL-1β.
Dose is everything: at high concentrations methylene blue becomes pro-oxidant, generating ROS and worsening collapse.
Translational scaling: 10 mg/kg (rat) ≈ 1.6 mg/kg (human), within the clinical bolus range 1–4 mg/kg.
Lactate may lag behind MAP: macro stabilization precedes microcellular recovery.
Limitations: 12-hour window, no long-term survival/infusion data, female-only cohort and potential estrogen “buffer.”
-
Episode timeline
0:19–1:36 — The ICU paradox: brute-force stabilization can starve the microsystem
1:36–3:24 — Paper setup + why a microdose of methylene blue challenges standard critical care
3:24–5:23 — Vasoplegia mechanics: iNOS overexpression, NO flood, sGC/cGMP “relaxation jam”
5:23–7:50 — Why vasopressors backfire: “duct tape” constriction → microvascular hypoperfusion → organ ischemia; “de-catecholaminization”
7:50–9:51 — Why methylene blue is different: redox agent + blocks NO signaling at sGC and suppresses iNOS
9:51–11:26 — Why CLP (cecal ligation & puncture) models real sepsis better than endotoxin injection
11:26–12:16 — Dose-mapping design: 10 vs 50 vs 100 mg/kg and the “razor-thin” window
12:16–15:42 — 10 mg/kg “Goldilocks” outcomes: MAP recovery, lung protection (PF ratio), kidney function (urea), ↓ IL-1β, redox improvements
15:42–17:30 — 100 mg/kg failure: pro-oxidant flip, acid-base collapse, ALT spike, early mortality
17:30–19:17 — Translational math: body-surface-area scaling → ~1.6 mg/kg human; aligns with 1–4 mg/kg ICU range
19:17–22:27 — Limitations: 12-hour snapshot, lactate lag, infusion questions; why you can’t “chase lactate” instantly
22:27–24:35 — Sex-hormone confound: female-only cohort, estrogen’s endothelial/anti-inflammatory buffering; need dual-sex replication
24:35–27:39 — Final synthesis: save microvasculature, not just monitor numbers; broader redox implications for chronic inflammation
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
Instagram
LinkedIn

BioLight:
Website
Instagram
YouTube
Facebook
28 min

About The Energy Code

From the publisher's feed

The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true…